PRESS RELEASE published on 11/27/2023 at 13:30, 2 years 6 months ago FSD Pharma Inc. Obtains Final Order for Plan of Arrangement
PRESS RELEASE published on 11/21/2023 at 14:45, 2 years 6 months ago FSD Pharma Inc. Securityholders Approve Plan of Arrangement with Celly Nutrition Corp.
PRESS RELEASE published on 11/17/2023 at 14:00, 2 years 7 months ago FSD Pharma Announces Distribution Date for Distribution of Celly Shares Pursuant to Plan of Arrangement
PRESS RELEASE published on 11/15/2023 at 15:00, 2 years 7 months ago FSD Pharma Files Supplement to Management Information Circular in Connection with Special Meeting to be Held on November 20, 2023
PRESS RELEASE published on 11/07/2023 at 17:45, 2 years 7 months ago FSD Pharma Provides Update on Proposed Dividend Distribution for Shareholders of FSD Pharma to Receive Shares of Celly Nutrition on a One for One Basis
PRESS RELEASE published on 10/23/2023 at 15:00, 2 years 7 months ago FSD Pharma Files Management Information Circular for Proposed Arrangement with Celly Nu
PRESS RELEASE published on 10/05/2023 at 13:30, 2 years 8 months ago FSD Pharma and Celly Nu Enter Into Arrangement Agreement
PRESS RELEASE published on 10/04/2023 at 14:30, 2 years 8 months ago FSD Pharma Wins $2.8 Million Dollar Award Plus Accruing Interest from Dr. Raza Bokhari; Set Aside Motion Brought by Bokhari, Now CEO of Medicus Pharma, Dismissed by the Ontario Superior Court of Justice
PRESS RELEASE published on 09/18/2023 at 13:30, 2 years 9 months ago FSD Pharma announces Interim Results from First-in-Human Clinical Trial of Lucid-MS (Lucid-21-302) for Multiple Sclerosis; The Report Shows Compound to be Safe and Well Tolerated
PRESS RELEASE published on 08/02/2023 at 13:30, 2 years 10 months ago FSD Pharma Signs Definitive Agreement to Launch UNBUZZD, a Revolutionary Rapid Alcohol Detoxification Drink
Published on 06/20/2026 at 01:00, 23 hours 54 minutes ago Onco-Innovations Announces Non-Brokered LIFE Offering
Published on 06/20/2026 at 00:00, 1 day ago Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development
Published on 06/19/2026 at 04:30, 1 day 20 hours ago Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp
Published on 06/19/2026 at 01:20, 1 day 23 hours ago American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting
Published on 06/19/2026 at 01:07, 1 day 23 hours ago Usha Resources Announces Share Issuance in Payment of Debenture Interest, Adopts Semi-Annual Reporting
Published on 06/20/2026 at 21:25, 3 hours 28 minutes ago VIVATECH 2026 CELEBRATES ITS 10TH ANNIVERSARY WITH A RECORD EDITION SURPASSING 200,000 VISITORS
Published on 06/20/2026 at 06:00, 18 hours 54 minutes ago Successful debut of International Symposium on Emergency Response and Aeromedical Services in Hong Kong
Published on 06/19/2026 at 20:17, 1 day 4 hours ago 2CRSi SA: 2CRSi Responds Point-by-Point to the Grizzly Research Report and Reaffirms the Reality of Its Business Operations
Published on 06/19/2026 at 19:01, 1 day 5 hours ago Fuller, Smith & Turner PLC: Publication of the Annual Report and Accounts for the 52 weeks ending 28 March 2026 and Notice of 2026 Annual General Meeting
Published on 06/19/2026 at 19:33, 1 day 5 hours ago Disclosure of transactions in own shares from June 15 to June 19, 2026
Published on 06/19/2026 at 19:23, 1 day 5 hours ago Imerys-06-2026-information-share-capital-and-voting-rights-as-of-31-May-2026
Published on 06/18/2026 at 18:00, 2 days 6 hours ago Outstanding shares and voting rights statement at 31 May 2026
Published on 06/18/2026 at 17:45, 2 days 7 hours ago EURAZEO INVESTS IN LAURALU, A PAN-EUROPEAN PROVIDER OF DEPLOYABLE INDUSTRIAL INFRASTRUCTURE
Published on 06/18/2026 at 17:38, 2 days 7 hours ago Statement of transactions in own shares from June 8, 2026 to June 12, 2026
